Y-DDC Compound Libraries 

Currently Y-DDC offers four specialized small molecule libraries designed for diverse screening applications: 

FDA-Approved & Pharmacopoeia Drug Library: A comprehensive collection of 3,400 compounds approved by major global regulatory agencies (FDA, EMA, PMDA, NMPA) and recognized pharmacopoeias (USP, BP, JP). This library is an ideal resource for drug repositioning and cellular induction studies.

Kinase Inhibitor Library: Comprising 2,955 selective kinase inhibitors and regulators, this library serves as a critical asset for chemical genomics, pharmacological studies, and targeted drug screening for kinase-related diseases. 

Natural Product Library: Containing 2,534 natural product monomers with high drug-likeness and structural diversity. This collection provides a robust foundation for structure-activity relationship (SAR) optimization and the discovery of novel bioactive lead compounds.

Drug-like Small Molecule Diversity Library: A large-scale collection of 50,000 compounds selected to maximize scaffold diversity and chemical space coverage. This library is optimized for high-throughput screening to rapidly identify novel bioactive hits across a broad chemical space. 

 Y-DDC Research Equipment 

FLIPR Penta High-Throughput Cellular Screening System: A premier high-throughput platform engineered for real-time, kinetic analysis of live-cell responses. Featuring integrated automated liquid handling and sensitive detection, the system supports a diverse array of functional assays, including calcium flux, GPCR signaling, ion channel modulation, and membrane potential monitoring, ensuring robust and reproducible data for drug discovery pipelines.

High-Performance Multi-Mode Microplate Reader: A versatile detection system providing high-sensitivity measurements for absorbance, fluorescence, and luminescence. Optimized for a broad spectrum of applications—from biochemical assays to complex cellular screenings—this platform delivers the precision and reproducibility essential for rigorous biomedical research.

Advanced Cell Culture Facility: A specialized environment equipped with state-of-the-art biological safety cabinets (BSCs) and dedicated sterile workstations. Our facility is designed to support high-integrity cell culture workflows, ensuring a seamless transition from preparation to high-throughput screening and facilitating reliable, standardized experimental outcomes.